![Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds](/docs/US/2017-08-22/US09737517B2/abs.jpg.600x600.jpg)
- Patent Title: Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds
-
Application No.: US14888797Application Date: 2014-05-04
-
Publication No.: US09737517B2Publication Date: 2017-08-22
- Inventor: Hong Liu , Xin Xie , Haifeng Sun , Jing Li , Fei Zhao , Ying Chen , Zeng Li , Yu Zhou , Hualiang Jiang , Kaixian Chen
- Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Current Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Current Assignee Address: CN Shanghai
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: CN201310161512 20130503
- International Application: PCT/CN2014/076743 WO 20140504
- International Announcement: WO2014/177065 WO 20141106
- Main IPC: A61K31/4375
- IPC: A61K31/4375
![Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds](/abs-image/US/2017/08/22/US09737517B2/abs.jpg.150x150.jpg)
Abstract:
Use of hexahydro-dibenzo[a,g]quinolizine compounds as shown in formula(I) in preparing a medicine for treating and/or preventing benign prostate hyperplasia diseases.
Public/Granted literature
- US20160193195A1 PHARMACEUTICAL USE OF HEXAHYDRO-DIBENZO[A,G]QUINOLIZINE COMPOUNDS Public/Granted day:2016-07-07
Information query
IPC分类:
